Intellia Therapeutics shares owned by MPM Oncology Impact Management
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by MPM Oncology Impact Management
from 13F filings
Historical chart of MPM Oncology Impact Management investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by MPM Oncology Impact Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $17M | 545k | 31.62 |
| 2023-06-30 | $22M | 545k | 40.78 |
| 2023-03-31 | $21M | 573k | 37.27 |
| 2022-12-31 | $16M | 455k | 34.89 |
| 2022-09-30 | $21M | 374k | 55.96 |
| 2022-06-30 | $16M | 299k | 51.76 |
| 2022-03-31 | $12M | 159k | 72.67 |
| 2021-12-31 | $19M | 161k | 118.24 |
| 2021-09-30 | $22M | 163k | 134.15 |
| 2020-12-31 | $7.0M | 128k | 54.40 |
More positions owned by MPM Oncology Impact Management
View all positions for MPM Oncology Impact Management